143 related articles for article (PubMed ID: 16103711)
1. Mycobacterial gene cloning and expression, comparative genomics, bioinformatics and proteomics in relation to the development of new vaccines and diagnostic reagents.
Mustafa AS
Med Princ Pract; 2005; 14 Suppl 1():27-34. PubMed ID: 16103711
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics: how it is being used to identify bacterial vaccine candidates.
Zagursky RJ; Olmsted SB; Russell DP; Wooters JL
Expert Rev Vaccines; 2003 Jun; 2(3):417-36. PubMed ID: 12903807
[TBL] [Abstract][Full Text] [Related]
3. Recombinant and synthetic peptides to identify Mycobacterium tuberculosis antigens and epitopes of diagnostic and vaccine relevance.
Mustafa AS
Tuberculosis (Edinb); 2005; 85(5-6):367-76. PubMed ID: 16253561
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
6. A proteome-scale identification of novel antigenic proteins in Mycobacterium tuberculosis toward diagnostic and vaccine development.
Li Y; Zeng J; Shi J; Wang M; Rao M; Xue C; Du Y; He ZG
J Proteome Res; 2010 Sep; 9(9):4812-22. PubMed ID: 20690665
[TBL] [Abstract][Full Text] [Related]
7. Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis.
Mustafa AS
Curr Pharm Biotechnol; 2001 Jun; 2(2):157-73. PubMed ID: 11480420
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Mycobacterium tuberculosis genoma and production of a recombinant protein containing specific B and T cell antigenic determinants--new approaches to second generation antituberculosis vaccines.
Colizzi V; Vismara D; D'Urso C; Mezzopreti MF; Lombardi G; Piccolella E; Damiani G; Marelli P; Campa M
Z Erkr Atmungsorgane; 1989; 172(1):40-52. PubMed ID: 2467445
[TBL] [Abstract][Full Text] [Related]
9. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
10. Cloning, expression, and immunogenicity of novel fusion protein of Mycobacterium tuberculosis based on ESAT-6 and truncated C-terminal fragment of HSP70.
Tebianian M; Hoseini AZ; Ebrahimi SM; Memarnejadian A; Mokarram AR; Mahdavi M; Sohrabi N; Taghizadeh M
Biologicals; 2011 May; 39(3):143-8. PubMed ID: 21388826
[TBL] [Abstract][Full Text] [Related]
11. The impact of genomics on vaccine design.
Scarselli M; Giuliani MM; Adu-Bobie J; Pizza M; Rappuoli R
Trends Biotechnol; 2005 Feb; 23(2):84-91. PubMed ID: 15661345
[TBL] [Abstract][Full Text] [Related]
12. Identification of a specific Mycobacterium tuberculosis protein able to activate T lymphocytes.
Vismara D; Favaro M; Mariani F; Piccolella E; Colizzi V
Ann Ist Super Sanita; 1991; 27(1):21-6. PubMed ID: 1720294
[TBL] [Abstract][Full Text] [Related]
13. [Molecular cloning and expression of Mycobacterium tuberculosis Aoyama B peptide antigen genes in Escherichia coli--a gene encoding 60 kD antigen (AT201) and immunological activity of recombinant peptides (15 and 60 kD)].
Tanaka-Hayashi T; Tsuyuguchi T; Aoyama K; Okamura H; Nagata K; Tamura T; Yamamoto Y; Furuyama J; Komatsu T; Shin-Ka S
Kekkaku; 1990 Aug; 65(8):507-17. PubMed ID: 2120504
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning, expression, purification and immunological characterization of three low-molecular weight proteins encoded by genes in genomic regions of difference of mycobacterium tuberculosis.
Hanif SN; Al-Attiyah R; Mustafa AS
Scand J Immunol; 2010 May; 71(5):353-61. PubMed ID: 20500686
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis.
Coler RN; Skeiky YA; Vedvick T; Bement T; Ovendale P; Campos-Neto A; Alderson MR; Reed SG
J Immunol; 1998 Sep; 161(5):2356-64. PubMed ID: 9725231
[TBL] [Abstract][Full Text] [Related]
16. Immunological characterization of novel secreted antigens of Mycobacterium tuberculosis.
Ben Amor Y; Shashkina E; Johnson S; Bifani PJ; Kurepina N; Kreiswirth B; Bhattacharya S; Spencer J; Rendon A; Catanzaro A; Gennaro ML
Scand J Immunol; 2005 Feb; 61(2):139-46. PubMed ID: 15683450
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccines against mycobacterial diseases.
Romano M; Huygen K
Expert Rev Vaccines; 2009 Sep; 8(9):1237-50. PubMed ID: 19722896
[TBL] [Abstract][Full Text] [Related]
18. Exploring functional genomics for the development of novel intervention strategies against tuberculosis.
Rachman H; Kaufmann SH
Int J Med Microbiol; 2007 Nov; 297(7-8):559-67. PubMed ID: 17467338
[TBL] [Abstract][Full Text] [Related]
19. Expression systems for study of mycobacterial gene regulation and development of recombinant BCG vaccines.
DasGupta SK; Jain S; Kaushal D; Tyagi AK
Biochem Biophys Res Commun; 1998 May; 246(3):797-804. PubMed ID: 9618292
[TBL] [Abstract][Full Text] [Related]
20. New ways to identify novel bacterial antigens for vaccine development.
Movahedi AR; Hampson DJ
Vet Microbiol; 2008 Sep; 131(1-2):1-13. PubMed ID: 18372122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
